Research synthesisLow evidenceSmall effect4 studies · 2 beneficial · 2 neutral · 0 harmful
Across 4 studies, 2 reported beneficial effects and 2 reported neutral effects, with a predominance of small effect sizes. The most common dose was 500 mg twice daily, and the median study duration was 84 days (12 weeks), suggesting effects are typically observed at this timeframe. Available evidence shows mixed results, with the strongest individual RCTs finding no significant difference between berberine and placebo for triglyceride reduction, while meta-analyses report small-to-moderate benefits.
- Effective dose range: 500 mg twice daily
- Studied populations: clinical populations including men with hyperlipidemia and patients with type 2 diabetes
Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. The two neutral RCTs have higher evidence quality scores than the beneficial meta-analyses, creating a disconnect between individual trial results and pooled analyses.
Generated Jul 15, 2026